Senate report reveals up to 477% increases in top 20 prescription drugs in Federal Program
ePharmacies, announced today that it is offering savings of up to 90% on prescription medications. The government research revealed that the most common drugs prescribed under the Medicare Part D program have surged in price, with some medicines now 477% more costly than they were just five years ago.— Reacting to a recent U.S. Senate report on dramatic price increases for Medicare Part D drugs,
“This is a major issue for seniors today,” said Cary Byrd, CEO of ePharmacies.com. “For people on fixed incomes, a large price increase can lead to non-compliance with much-needed medication regimens that affect health and longevity. It can also create undue financial hardship. These are the problems we solve.”
According to a report from the U.S. Senate Committee on Homeland Security and Governmental Affairs, drug prices are outpacing inflation. Initiated by Senator Claire McCaskill (D-MO), the report states that the 20 most widely-prescribed drugs in Medicare Part D have increased 12%, on average, since 2012. Twelve of these medications have experienced a price increase greater than 50% while one, the heart drug Nitrostat, shot up by 477% in cost.
Almost all of these drugs described in the report are available for savings of up to 90% through ePharmacies.com, which deals with online pharmacies with verified credentials. And, interestingly, it turns out that 70% of the drugs in the report are not even manufactured in the United States. They are being imported already.
ePharmacies.com provides consumers with a free cost-comparison tool. This helps them safely locate a licensed online pharmacy that provides privacy, convenience and lower prescription prices. The result is greatly improved access to low-cost generic prescription drugs.
# # #
Release ID: 461418